Diagnostics pre-clinical services program - IDIQ - MRI global

Active Indefinite Delivery Contract Awarded Last action

Contract number
75N93023D00017
Awardee
Awarding agency
Task orders
6 $2,742,137 obligated

Award facts

Opportunity
Combined order value
  • $2,742,137 Current, with exercised options
  • $2,852,917 Potential, with all options
Last date to order 48% complete
IDV ceiling 11% used
$24,000,000.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 12 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

This federal contract award is an Indefinite Delivery, Indefinite Quantity (IDIQ) contract for the Diagnostics Pre-Clinical Services Program, awarded by the Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases to the prime contractor MRI Global, also doing business as Midwest Research Institute. The contract has a potential value of $24,000,000 and a period of performance through June 2030. Under this IDIQ, MRI Global will provide a broad range of services to support the development of in vitro diagnostic products for the detection, identification, and characterization of human infectious agents, including product development processes, reagents, clinical specimens, and manufacturing services. Two specific task orders have been awarded to date, each valued at $3,500 on a firm fixed price basis, for MRI Global to deliver diagnostics pre-clinical services in support of the agency's program to develop medical countermeasures against infectious diseases. The work will be performed in Kansas City, Missouri, and no set-asides were applied to this acquisition.

The original solicitation was a pre-solicitation notice seeking capability statements from qualified small businesses to potentially provide these diagnostic pre-clinical services under an IDIQ contract. The agency indicated it anticipated making multiple IDIQ contract awards with a 7-year ordering period starting in June 2023. The goal is to offer a comprehensive array of capabilities to product developers, helping them obtain critical data and complete studies to advance new in vitro diagnostic products toward regulatory clearance.

Task orders

Transactions

Action Obligated Date
Other Administrative Action P00001 · Change key personnel. $0
Original award $0

Subawards

Subcontractor Amount Awarded
Subcontractor not on record DIAGNOSTICS PRE-CLINICAL SERVICES PROGRAM Antibody Testing $437,600

Quick answers

Who was awarded contract 75N93023D00017?

75N93023D00017 was awarded to Mriglobal by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 20, 2023.

How much is contract 75N93023D00017 worth?

Orders under 75N93023D00017 have obligated $2,742,137. Their combined potential value, with all options, is $2,852,917. 75N93023D00017's own ceiling is $24,000,000.

How many orders have been placed under contract 75N93023D00017?

6 orders have been placed under 75N93023D00017, the latest on September 1, 2026.

Who can order from contract 75N93023D00017?

75N93023D00017 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 75N93023D00017 competed?

The extent of competition for 75N93023D00017 was full and open competition. The government received 12 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV